Work

Effect of STK11 mutations on efficacy of PD-1 inhibition in non-small cell lung cancer (NSCLC) and dependence on KRAS mutation status.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.e15113

Authors: Biagio Ricciuti, Kathryn Cecilia Arbour, Jessica Jiyeong Lin, Natalie Vokes, Amir Vajdi Hoojghan, Yvonne Y. Li, Andrew D. Cherniack, Gonzalo Recondo, Giuseppe Lamberti, Deepti Venkatraman, Hira Rizvi, Jacklynn V. Egger, Andrew J. Plodkowski, Sara Khosrowjerdi, Subba R Digumarthy, Mizuki Nishino, Lynette M. Sholl, Justin F. Gainor, Matthew David Hellmann, Mark M. Awad

Institutions: Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Massachusetts General Hospital, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3031165095

Cites:

Cited by: 10

Related to: 10